Literature DB >> 3154328

Intracellular calcium in heart failure.

J P Morgan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3154328     DOI： 10.1007/bf02125749

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  8 in total

Review 1.  Role of cyclic nucleotides in heart metabolism.

Authors:  L H Opie
Journal:  Cardiovasc Res       Date:  1982-09       Impact factor: 10.787

2.  Altered calcium handling in experimental pressure-overload hypertrophy in the ferret.

Authors:  J K Gwathmey; J P Morgan
Journal:  Circ Res       Date:  1985-12       Impact factor: 17.367

3.  Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure.

Authors:  J K Gwathmey; L Copelas; R MacKinnon; F J Schoen; M D Feldman; W Grossman; J P Morgan
Journal:  Circ Res       Date:  1987-07       Impact factor: 17.367

4.  Intracellular calcium transients in human working myocardium as detected with aequorin.

Authors:  J P Morgan; J H Chesebro; J R Pluth; F J Puga; H V Schaff
Journal:  J Am Coll Cardiol       Date:  1984-02       Impact factor: 24.094

5.  Cyclic adenosine monophosphate effects on the myocardium: a man who blows hot and cold with one breath.

Authors:  A M Katz
Journal:  J Am Coll Cardiol       Date:  1983-07       Impact factor: 24.094

6.  Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol.

Authors:  R Ginsburg; M R Bristow; M E Billingham; E B Stinson; J S Schroeder; D C Harrison
Journal:  Am Heart J       Date:  1983-09       Impact factor: 4.749

7.  Calcium and cardiovascular function. Intracellular calcium levels during contraction and relaxation of mammalian cardiac and vascular smooth muscle as detected with aequorin.

Authors:  J P Morgan; K G Morgan
Journal:  Am J Med       Date:  1984-11-05       Impact factor: 4.965

8.  Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.

Authors:  M D Feldman; L Copelas; J K Gwathmey; P Phillips; S E Warren; F J Schoen; W Grossman; J P Morgan
Journal:  Circulation       Date:  1987-02       Impact factor: 29.690
  8 in total
  1 in total

1.  Differential inotropic effects of flosequinan in ventricular muscle from normal ferrets versus patients with end-stage heart failure.

Authors:  C L Perreault; N L Hague; E Loh; I M Hunneyball; M F Sim; J P Morgan
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.